Truscreen Group Ltd
Company Profile
- Business description- Truscreen Group Ltd is a medical device company. The company manufactures and distributes the Truscreen Cervical Cancer screening device, which comprises a medical device and process designed to detect the presence in real-time of precancerous and cancerous tissue on the cervix. The product utilizes technology to detect the pre-cancerous change, or cervical intraepithelial neoplasia (CIN), by optical and electrical measurements of cervical tissue. Geographically, the company operates its business in New Zealand, Mexico, China, Russia, Zimbabwe, Vietnam, and other countries. Maximum revenue is generated from China. 
- Contact- C/- HLB Mann Judd Limited 
 57 Symonds Street
 Level 6, Equitable House
 Grafton
 Auckland1010
 NZL- T: +64 93032243 
- Sector- Healthcare - Stock type- Defensive 
- Industry- Medical Devices - Fiscal Year End- 31 March 2026 - Employees- 9 
Stocks News & Analysis
stocks
Microsoft earnings: Strong, including Azure, but overall guidance is in line
stocks
After earnings, is Tesla stock a buy, a sell, or fairly valued?
Morningstar Investment Ideas
Markets
| Index | Last price | Change | % Change | 
|---|---|---|---|
| All Ordinaries | 9,206.70 | 32.80 | 0.36% | 
| CAC 40 | 8,147.35 | 53.53 | -0.65% | 
| DAX 40 | 24,118.89 | 5.32 | -0.02% | 
| Dow JONES (US) | 47,522.12 | 109.88 | -0.23% | 
| FTSE 100 | 9,721.06 | 35.08 | -0.36% | 
| HKSE | 26,282.69 | 63.45 | -0.24% | 
| NASDAQ | 23,581.14 | 377.33 | -1.57% | 
| Nikkei 225 | 51,325.61 | 17.96 | 0.04% | 
| NZX 50 Index | 13,498.36 | 39.07 | 0.29% | 
| S&P 500 | 6,822.34 | 68.25 | -0.99% | 
| S&P/ASX 200 | 8,913.20 | 33.20 | 0.37% | 
| SSE Composite Index | 3,986.90 | 29.43 | -0.73% |